Zurueck zur Suche

Reporte zur Charge U039723

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

22Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MD 9 NE 2 WI 2 MI 2 VA 2 MA 1 SC 1 KY 1 NJ 1 NY 1

VAERS 2399315

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

moderat
Staat
NE
Alter
49,0
Geschlecht
F
Eingang
02.08.2022
Impfdatum
02.08.2022
Beginn
02.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood pressure increased Dyspnoea exertional Headache Ocular discomfort Pruritus

Symptomtext

onset of internal itching; followed by pressure and itching behind her eyes had some mild shortness of breath while walking; headache temp 99.8; elevated B/P 178/97; HR 102 TX: Benadryl 25mg p.o.; Ibuprofen 400mg p.o.; rest

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea exertional
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
UTI
Vorgeschichte
diabetes; depression; PTSD; anxiety; fibromyalgia; hypertension
Andere Medikamente
Edarbyclor; metoprolol; humalog; trulicity; cymbalta; mirapex
Allergien
levoquin; CT iodine; compazine; codeine; augmentin
Vorherige Impfungen
-

VAERS 2426483

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

mild
Staat
WI
Alter
6,0
Geschlecht
F
Eingang
01.09.2022
Impfdatum
29.08.2022
Beginn
29.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Headache Nausea

Symptomtext

Headache, nausea starting 13 hours after vaccines with crying due to headache for two days, improving now at 72 hours post-vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
GI upset/nausea for a stretch starting four weeks prior to vaccines.
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2413335

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

mild
Staat
NE
Alter
45,0
Geschlecht
F
Eingang
17.08.2022
Impfdatum
15.08.2022
Beginn
15.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Headache Musculoskeletal stiffness Peripheral swelling Pyrexia Vision blurred

Symptomtext

fever, red swollen arm, headache, stiff neck, blurry vision

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
No
Andere Medikamente
None
Allergien
Latex
Vorherige Impfungen
-

VAERS 2362577

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

mild
Staat
MA
Alter
21,0
Geschlecht
F
Eingang
08.07.2022
Impfdatum
05.07.2022
Beginn
05.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pruritus Injection site swelling Injection site warmth Tuberculin test negative

Symptomtext

21 y/o F presented to Health Services on 7/5/22 for varicella vaccine, MCV4 (Menveo) vaccine and PPD placement. Pt returned on 7/7/22 for PPD reading (negative) and reported to nurse that there was redness at the injection site of her varicella vaccine. Pt reported that the area was also itchy and that the redness had spread a little bit each day since her vaccine. Pt denied fever and malaise. Area was assessed by nurse and nurse practitioner. Area of 48 mm x 27 mm on posterior aspect of left upper arm was red, swollen and warm to the touch. Outline was drawn around area and pt was told to return the next day, 7/8/22, at 3 pm to have the area reassessed. Nurse practitioner recommended to the pt that she try taking an OTC antihistamine such as loratadine to see if this helps relieve the itchiness. Pt agreed to this plan. Pt called Health Services the next morning to cancel her appointment for 3 pm that day stating the area had improved. Nurse called the patient back to get more details. Pt confirmed the area of redness was now smaller than the outline drawn around it the day before (7/7/22). Pt stated the redness and swelling had decreased and that it was no longer warm to the touch or itchy. Pt reported she took one tablet of loratadine the night before and stated the area has not been itchy since then. Pt denied fever and having redness/swelling/itchiness anywhere else on her body. Pt instructed to go to an Urgent Care if over the weekend the redness/swelling/itchiness returns/gets worse or spreads to other areas, and/or she develops a fever. Pt agreed to this plan.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
None
Allergien
NKDA Pineapple
Vorherige Impfungen
-

VAERS 2338852

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

mild
Staat
SC
Alter
5,0
Geschlecht
M
Eingang
28.06.2022
Impfdatum
21.06.2022
Beginn
21.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site inflammation

Symptomtext

Left arm with pronounced post inflammatory site reaction after Varicella vaccine, improved the following day when patient was evaluated in office.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site inflammation
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
NKA
Vorherige Impfungen
-

VAERS 2645138

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MD
Alter
-
Geschlecht
F
Eingang
14.06.2023
Impfdatum
15.05.2023
Beginn
15.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no aditional AE; freezer underwent an excursion and they did not realize the excursion until later/temperature excursion for VARIVAX and PROQUAD/ VARIVAX and PROQUAD may have been administered to multiple patients; This spontaneous report has been received from a nurse, concerning a 12-month-old female patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided. On 15-MAY-2023, the reporter's freezer underwent a temperature excursion; in which varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) were stored. On that same day, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W035466 and W017567 with following expiration dates 06-MAY-2024 and 29-NOV-2023, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided). Other suspect therapies included varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723 and W031812 with following expirations dates 15-DEC-2023 and 05-OCT-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided) (product storage error and no adverse event).; Sender's Comments: US-009507513-2306USA004082: US-009507513-2306USA004088: US-009507513-2306USA004089: US-009507513-2306USA004090: US-009507513-2306USA004087: US-009507513-2306USA004086: US-009507513-2305USA007959: US-009507513-2306USA004083: US-009507513-2306USA004084:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2645137

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MD
Alter
-
Geschlecht
M
Eingang
14.06.2023
Impfdatum
15.05.2023
Beginn
15.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no aditional AE; freezer underwent an excursion and they did not realize the excursion until later/temperature excursion for VARIVAX and PROQUAD/ VARIVAX and PROQUAD may have been administered to multiple patients; This spontaneous report has been received from a nurse, concerning a 3-year-old male patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided. On 15-MAY-2023, the reporter's freezer underwent a temperature excursion; in which varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) were stored. On that same day, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W035466 and W017567 with following expiration dates 06-MAY-2024 and 29-NOV-2023, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided). Other suspect therapies included varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723 and W031812 with following expirations dates 15-DEC-2023 and 05-OCT-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided) (product storage error and no adverse event). .; Sender's Comments: US-009507513-2306USA004088: US-009507513-2306USA004087: US-009507513-2306USA004086: US-009507513-2306USA004089: US-009507513-2306USA004085: US-009507513-2306USA004082: US-009507513-2306USA004090: US-009507513-2306USA004083: US-009507513-2305USA007959:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2645136

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MD
Alter
0,9
Geschlecht
M
Eingang
14.06.2023
Impfdatum
15.05.2023
Beginn
15.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no aditional AE; freezer underwent an excursion and they did not realize the excursion until later/temperature excursion for VARIVAX and PROQUAD/ VARIVAX and PROQUAD may have been administered to multiple patients; This spontaneous report has been received from a nurse, concerning a 11-month-old male patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided. On 15-MAY-2023, the reporter's freezer underwent a temperature excursion; in which varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) were stored. On that same day, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W035466 and W017567 with following expiration dates 06-MAY-2024 and 29-NOV-2023, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided). Other suspect therapies included varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723 and W031812 with following expirations dates 15-DEC-2023 and 05-OCT-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided) (product storage error and no adverse event).; Sender's Comments: US-009507513-2306USA004086: US-009507513-2306USA004087: US-009507513-2306USA004090: US-009507513-2306USA004089: US-009507513-2306USA004085: US-009507513-2306USA004084: US-009507513-2306USA004088: US-009507513-2306USA004082: US-009507513-2305USA007959:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644841

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MD
Alter
-
Geschlecht
M
Eingang
13.06.2023
Impfdatum
15.05.2023
Beginn
15.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no aditional AE; freezer underwent an excursion and they did not realize the excursion until later/temperature excursion for VARIVAX and PROQUAD/ VARIVAX and PROQUAD may have been administered to multiple patients; This spontaneous report has been received from a nurse, concerning a 4-year-old male patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided. On 15-MAY-2023, the reporter's freezer underwent a temperature excursion; in which varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) were stored. On that same day, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W035466 and W017567 with following expiration dates 06-MAY-2024 and 29-NOV-2023, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided). Other suspect therapies included varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723 and W031812 with following expirations dates 15-DEC-2023 and 05-OCT-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided) (product storage error and no adverse event).; Sender's Comments: US-009507513-2306USA004082: US-009507513-2306USA004086: US-009507513-2306USA004087: US-009507513-2306USA004088: US-009507513-2306USA004089: US-009507513-2306USA004085: US-009507513-2305USA007959: US-009507513-2306USA004084: US-009507513-2306USA004083:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644840

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MD
Alter
-
Geschlecht
M
Eingang
13.06.2023
Impfdatum
15.05.2023
Beginn
15.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no aditional AE; freezer underwent an excursion and they did not realize the excursion until later/temperature excursion for VARIVAX and PROQUAD/ VARIVAX and PROQUAD may have been administered to multiple patients; This spontaneous report has been received from a nurse, concerning a 3-year-old male patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided. On 15-MAY-2023, the reporter's freezer underwent a temperature excursion; in which varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) were stored. On that same day, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W035466 and W017567 with following expiration dates 06-MAY-2024 and 29-NOV-2023, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided). Other suspect therapies included varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723 and W031812 with following expirations dates 15-DEC-2023 and 05-OCT-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided) (product storage error and no adverse event).; Sender's Comments: US-009507513-2306USA004082: US-009507513-2306USA004090: US-009507513-2306USA004086: US-009507513-2306USA004087: US-009507513-2306USA004088: US-009507513-2305USA007959: US-009507513-2306USA004085: US-009507513-2306USA004084: US-009507513-2306USA004083:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644839

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MD
Alter
-
Geschlecht
M
Eingang
13.06.2023
Impfdatum
15.05.2023
Beginn
15.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no aditional AE; freezer underwent an excursion and they did not realize the excursion until later/temperature excursion for VARIVAX and PROQUAD/ VARIVAX and PROQUAD may have been administered to multiple patients; This spontaneous report has been received from a nurse, concerning a 12-month-old male patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided. On 15-MAY-2023, the reporter's freezer underwent a temperature excursion; in which varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) were stored. On that same day, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W035466 and W017567 with following expiration dates 06-MAY-2024 and 29-NOV-2023, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided). Other suspect therapies included varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723 and W031812 with following expirations dates 15-DEC-2023 and 05-OCT-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided) (product storage error and no adverse event).; Sender's Comments: US-009507513-2306USA004090: US-009507513-2306USA004089: US-009507513-2306USA004086: US-009507513-2306USA004087: US-009507513-2305USA007959: US-009507513-2306USA004085: US-009507513-2306USA004083: US-009507513-2306USA004082: US-009507513-2306USA004084:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644838

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
13.06.2023
Impfdatum
15.05.2023
Beginn
15.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no aditional AE; freezer underwent an excursion and they did not realize the excursion until later/temperature excursion for VARIVAX and PROQUAD/ VARIVAX and PROQUAD may have been administered to multiple patients; This spontaneous report has been received from a nurse, concerning a 11-month-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided. On 15-MAY-2023, the reporter's freezer underwent a temperature excursion; in which varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) were stored. On that same day, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W035466 and W017567 with following expiration dates 06-MAY-2024 and 29-NOV-2023, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided). Other suspect therapies included varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723 and W031812 with following expirations dates 15-DEC-2023 and 05-OCT-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided) (product storage error and no adverse event).; Sender's Comments: US-009507513-2306USA004089: US-009507513-2306USA004090: US-009507513-2306USA004082: US-009507513-2306USA004088: US-009507513-2306USA004086: US-009507513-2305USA007959: US-009507513-2306USA004085: US-009507513-2306USA004083: US-009507513-2306USA004084:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644837

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MD
Alter
-
Geschlecht
F
Eingang
13.06.2023
Impfdatum
15.05.2023
Beginn
15.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no aditional AE; freezer underwent an excursion and they did not realize the excursion until later/temperature excursion for VARIVAX and PROQUAD/ VARIVAX and PROQUAD may have been administered to multiple patients; This spontaneous report has been received from a nurse, concerning a 12-month-old female patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided. On 15-MAY-2023, the reporter's freezer underwent a temperature excursion; in which varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) were stored. On that same day, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W035466 and W017567 with following expiration dates 06-MAY-2024 and 29-NOV-2023, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided). Other suspect therapies included varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723 and W031812 with following expirations dates 15-DEC-2023 and 05-OCT-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided) (product storage error and no adverse event).; Sender's Comments: US-009507513-2306USA004090: US-009507513-2306USA004089: US-009507513-2306USA004087: US-009507513-2306USA004082: US-009507513-2306USA004088: US-009507513-2305USA007959: US-009507513-2306USA004085: US-009507513-2306USA004083: US-009507513-2306USA004084:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644836

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MD
Alter
-
Geschlecht
F
Eingang
13.06.2023
Impfdatum
15.05.2023
Beginn
15.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no aditional AE; freezer underwent an excursion and they did not realize the excursion until later/temperature excursion for VARIVAX and PROQUAD/ VARIVAX and PROQUAD may have been administered to multiple patients; This spontaneous report has been received from a nurse, concerning female patient of unreported age. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided. On 15-MAY-2023, the reporter's freezer underwent a temperature excursion; in which varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) were stored. On that same day, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W017567 and expiration date 06-MAY-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided). Other suspect therapies included varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723 and W031812 with following expirations dates 15-DEC-2023 and 05-OCT-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided) (product storage error and no adverse event).; Sender's Comments: US-009507513-2306USA004089: US-009507513-2306USA004090: US-009507513-2306USA004084: US-009507513-2306USA004087: US-009507513-2306USA004085: US-009507513-2305USA007959: US-009507513-2306USA004083: US-009507513-2306USA004086:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644314

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
13.06.2023
Impfdatum
01.06.2023
Beginn
01.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Confirmed that there were no symptomatic adverse event reported; Inbound call from nurse who reported one dose of VARIVAX was administered following a temperature excursion. After evaluation, VARIVAX was found to be supported. Confirmed that there were no symptomatic adverse event reported. No additional inform; This spontaneous report has been received from a nurse, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 01-JUN-2023, the patient was vaccinated with an improperly storage dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection, at a dose of 0.5 milliliters (ml) once as prophylaxis (lot number: U039723, which was determined to be valid, with an expiration date on 15-DEC-2023) (scheme, route and anatomical location of administration were not reported) (Product storage error). The administered dose underwent a temperature excursion of between -10 and 8 Celsius (C), for 2 hours 50 minutes. No previous temperature excursion was reported. No additional symptomatic adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2430959

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
MI
Alter
4,0
Geschlecht
F
Eingang
07.09.2022
Impfdatum
06.09.2022
Beginn
07.09.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Pt received MMRV and Varicella on the same day

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2428346

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
KY
Alter
-
Geschlecht
U
Eingang
03.09.2022
Impfdatum
30.08.2022
Beginn
30.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; Caller reported that VARIVAX and PROQUAD that underwent a temperature excursion were administered; This spontaneous report has been received from a health care worker concerning to patient of unknown age and gender. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported. On an unknown date, a temperature excursion occurred for varicella virus vaccine live (oka/merck) (VARIVAX) in which the maximum temperature was from 6 to 14 degrees Fahrenheit for a timeframe of 50 minutes and 14 to 46 degrees Fahrenheit for a timeframe of 1 hour. No previous temperature excursions were reported. On 30-AUG-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723, expiration date 15-DEC-2023 (dose, route of administration and anatomical location were not provided) for prophylaxis (product storage error). No additional events were reported. This is one of three reports from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2418295

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u039723

gering
Staat
WI
Alter
57,0
Geschlecht
F
Eingang
23.08.2022
Impfdatum
23.08.2022
Beginn
23.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Patient was seen by me in our clinic. Client was to receive Twinrix, MMR and Varicella. When I pulled the vaccine to administer I pulled and administered Twinrix, ProQuad and Varicella.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
dust and dander
Vorherige Impfungen
-

VAERS 2411065

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
15.08.2022
Impfdatum
09.08.2022
Beginn
09.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE. No PQC.; Caller reporting a vaccine was administered after a temperature excursion.; This spontaneous report has been received from a nurse, regarding a patient of unknown age and gender. The patient"s medical history, current conditions, drug reaction or allergies and concomitant medications were not reported. On 09-AUG-2022, the patient was vaccinated with an improperly storage dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliters (ml) as prophylaxis (lot number: U039723, which was determined to be valid, with an expiration date on 15-DEC-2023) (route and anatomical location of administration were not reported) (Product storage error). Details regarding temperature excursion were not provided. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2369862

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
15.07.2022
Impfdatum
14.06.2022
Beginn
14.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE occurred; VARIVAX was administered after a temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported. On 14-JUN-2022, the patient vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection, at a dose reported as 1 dose, lot # U039723 with expiration date on 15-DEC-2023, administered subcutaneously for prophylaxis (strength, vaccination scheme frequency and anatomical location were not provided) (product storage error). The administered dose of the vaccine experienced a temperature excursion at -2.5 degrees Celsius (C) for a time frame of 5 hours and 6 minutes. It was stated that there were not previous temperature excursions. Additionally, it was confirmed that no adverse events occurred. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA005711: US-009507513-2206USA005588: US-009507513-2206USA005579: US-009507513-2206USA005817:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2342018

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039723

gering
Staat
VA
Alter
4,0
Geschlecht
F
Eingang
29.06.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect dose administered Product administered to patient of inappropriate age Wrong product administered

Symptomtext

My daughter was given the wrong vaccine and the wrong dose. She should have received (according to the doctor we saw today) Moderna, 3mg and she was given Pfizer, 10mg.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2293876

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u039723

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
25.05.2022
Impfdatum
23.05.2022
Beginn
20.05.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product label confusion Product label issue Product quality issue Product storage error

Symptomtext

No additional AE/PQC; The caller stated one of the doses of the product involved with this PQC, that was also improperly stored, was administered to a patient; wrong information on leaflet, there was a leaflet that was laminated with orange letters that stated VARIVAX can be stored in the refrigerator/ she then went onto Merck's website to check what the recommended storage range was for VARIVAX; wrong information on leaflet, there was a leaflet that was laminated with orange letters that stated VARIVAX can be stored in the refrigerator/ she then went onto Merck's website to check what the recommended storage range was for VARIVAX; This spontaneous report was received from a pharmacist, concerning a patient of unknown age and gender. The patient's pertinent medical history, and drug reactions or allergies were not reported. Concomitant therapies included sterile diluent. The pharmacist stated that she received a shipment of varicella virus vaccine live (oka/merck) (VARIVAX) which was unpacked on 20-MAY-2022, and according to the reporter "there was wrong information on leaflet", further described as: "there was a leaflet or form inside the shipment box, that was laminated with orange letters, that stated varicella virus vaccine live (oka/merck) (VARIVAX) could be stored in the refrigerator". The caller stated she then went into Merck's website to check what the recommended storage range was for varicella virus vaccine live (oka/merck) (VARIVAX) and she read that it could be stored in the refrigerator for up to 18 months (product label issue, product label confusion). The caller did not specify or provide any further information about the site she visited other than providing the link (exact site where she had read this information) and confirmed this prescribing information (PI) was not inside the shipment, but that she found this on the internet. The caller stated this shipment was stored in the refrigerator that same day (on 20-MAY-2022). Additional details included: the prescription was dispensed in original Merck vials; there were no other printing issues with the label; label was intact; label did not look like it had been exposed to moisture or increased humidity; carton had no damage; primary label was not affected; there were no issues with the shipment or packaging and the caller confirmed the information was legible. The reporter stated this leaflet or form that was included in the shipment had since been thrown away, so no pictures of the form were able to be sent. Besides, the caller stated that one of the doses of varicella virus vaccine live (oka/merck) (VARIVAX) vial (involved with this product quality complaint (PQC)) that was also improperly stored was administered to the patient on 23-MAY-2022 (reported as "today") (product storage error) as prophylaxis (strength, route of administration, and anatomical location were not reported; product quantity reported as: 1 (units not provided); lot number u039723 has been verified to be a valid lot number, expiration date: 15-DEC-2023). The diluent used for reconstitution dose was not improperly stored and was not involved in the PQC. No additional information provided to further clarify what the pharmacist read on the leaflet. No additional AE/PQC (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-